Fueling life sciences through transformative transactions
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.
Walk with us. Together, we’ll build lasting value.
Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
Sell-Side Engagement for Gritstone Leading to a Partnership with Gilead for $60M Upfront and $725M in Additional Payments plus Tiered Royalties
Fair market valuation supports a successful merger and downstream $4B acquisition.
Corporate, R&D, BD, and financing strategy and commercial analytics with strategic transactions and capital markets execution
Global reach with on-the-ground local presence and company and investor relationships in all major life science markets
Comprehensive coverage across biopharma and medtech segments
Each quarter we compile key statistics and trends on strategic transactions and financings.
You can download your report here.
Locust Walk has closed high value transactions for multiple clients across a variety of therapeutic areas and modalities. The breadth of our success includes sell-side, buy-side and financing deals. Examples of recent client engagements where Locust Walk served as a transaction advisor are listed below. We would encourage you to click on each case study and/or press release to learn about each assignment in greater detail.